Revolution Medicines, Inc. (RVMD) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 1.97B | 2.08B | 1.98B | 2.18B | 2.13B | 2.33B | 1.58B | 1.62B | 1.73B | 1.88B | 824.47M | 922.09M |
| Cash & Short-Term Investments | 1.91B | 2.03B | 1.93B | 2.14B | 2.1B | 2.29B | 1.55B | 1.59B | 1.7B | 1.85B | 813.2M | 909.49M |
| Cash Only | 440.94M | 383.75M | 217.44M | 402.44M | 333.55M | 543.06M | 201.26M | 275.71M | 288.43M | 696.15M | 358.4M | 380.33M |
| Short-Term Investments | 1.47B | 1.64B | 1.71B | 1.73B | 1.77B | 1.75B | 1.35B | 1.32B | 1.42B | 1.16B | 454.8M | 529.16M |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.25M | 309K | 2.51M |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | 96.9 | - | 77.4 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 59.83M | 49.36M | 0 | 39.27M | 31.91M | 38.33M | 29.66M | 34.02M | 25.66M | 25.07M | 10.96M | 10.09M |
| Total Non-Current Assets | 285.82M | 279.47M | 274.43M | 253.13M | 230.77M | 230.67M | 183.86M | 183.71M | 179.16M | 182.42M | 159.76M | 151.62M |
| Property, Plant & Equipment | 161.37M | 165.28M | 167.38M | 147.05M | 142.93M | 141.82M | 99.15M | 100.59M | 99.89M | 100.01M | 73.41M | 73.45M |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | 0.01x | - | 0.05x |
| Goodwill | 14.61M | 14.61M | 14.61M | 14.61M | 14.61M | 14.61M | 14.61M | 14.61M | 14.61M | 14.61M | 14.61M | 14.61M |
| Intangible Assets | 55.8M | 55.8M | 55.87M | 56.14M | 56.4M | 56.67M | 56.94M | 57.2M | 57.47M | 57.74M | 58.01M | 58.27M |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 54.05M | 43.78M | 36.58M | 35.34M | 16.83M | 17.57M | 13.16M | 11.3M | 7.19M | 10.06M | 13.74M | 5.29M |
| Total Assets | 2.25B | 2.35B | 2.25B | 2.43B | 2.37B | 2.56B | 1.76B | 1.81B | 1.91B | 2.06B | 984.23M | 1.07B |
| Asset Turnover | - | - | - | - | - | - | - | - | - | 0.00x | - | 0.00x |
| Asset Growth % | -4.72% | -7.97% | 27.73% | 34.35% | 23.95% | 24.09% | 79.12% | 68.43% | 77.81% | 153.93% | 19.17% | 69.68% |
| Total Current Liabilities | 289.6M | 290.42M | 245.62M | 184.53M | 158.6M | 163.91M | 110.86M | 105.33M | 93.72M | 143.85M | 85.54M | 78.06M |
| Accounts Payable | 80.54M | 64.62M | 74.85M | 56.76M | 47.51M | 54.43M | 24.46M | 29.32M | 32.38M | 61.79M | 29.63M | 29.78M |
| Days Payables Outstanding | - | 1.36K | - | - | - | - | - | - | - | - | - | - |
| Short-Term Debt | 16.61M | 16.47M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 192.45M | 209.34M | 0 | 22.19M | 14.1M | 31.36M | 20.36M | 15.39M | 10.54M | 27.51M | 13.31M | 9.51M |
| Current Ratio | 6.80x | 7.14x | 8.05x | 11.79x | 13.46x | 14.20x | 14.24x | 15.42x | 18.45x | 13.06x | 9.64x | 11.81x |
| Quick Ratio | 6.80x | 7.14x | 8.05x | 11.79x | 13.46x | 14.20x | 14.24x | 15.42x | 18.45x | 13.06x | 9.64x | 11.81x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 464.22M | 432.79M | 409.39M | 379.67M | 128.6M | 129.18M | 85.83M | 84.26M | 89.17M | 91.66M | 61.23M | 64.81M |
| Long-Term Debt | 140.02M | 142.23M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 142.13M | 119.7M | 121.36M | 122.97M | 78.31M | 79.08M | 79.86M | 80.58M | 57.09M | 57.54M |
| Deferred Tax Liabilities | 2.35M | 2.35M | 0 | 2.35M | 2.35M | 2.35M | 3.12M | 3.12M | 3.12M | 3.12M | 3.16M | 7.03M |
| Other Non-Current Liabilities | 321.85M | 288.2M | 267.26M | 257.61M | 4.89M | 3.86M | 4.41M | 2.06M | 6.2M | 7.97M | 982K | 252K |
| Total Liabilities | 753.82M | 723.21M | 655.02M | 564.2M | 287.2M | 293.1M | 196.69M | 189.59M | 182.9M | 235.51M | 146.77M | 142.87M |
| Total Debt | 156.63M | 158.7M | 158.46M | 132.79M | 134.34M | 135.84M | 86.71M | 87.41M | 88.03M | 87.94M | 62.85M | 63.26M |
| Net Debt | -284.31M | -225.04M | -58.98M | -269.65M | -199.21M | -407.22M | -114.56M | -188.3M | -200.4M | -608.2M | -295.55M | -317.07M |
| Debt / Equity | 0.10x | 0.10x | 0.10x | 0.07x | 0.06x | 0.06x | 0.06x | 0.05x | 0.05x | 0.05x | 0.08x | 0.07x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -36.50x | -29.57x | -25.71x | - | - | - | - | - | - | - | - | - |
| Total Equity | 1.5B | 1.63B | 1.6B | 1.87B | 2.08B | 2.27B | 1.57B | 1.62B | 1.73B | 1.83B | 837.46M | 930.84M |
| Equity Growth % | -27.82% | -27.98% | 1.95% | 15.23% | 20.44% | 24.04% | 87.03% | 73.91% | 81.2% | 166.52% | 22.9% | 86.6% |
| Book Value per Share | 7.57 | 8.58 | 8.44 | 9.91 | 11.05 | 13.50 | 9.39 | 9.80 | 10.47 | 12.93 | 7.67 | 8.71 |
| Total Shareholders' Equity | 1.5B | 1.63B | 1.6B | 1.87B | 2.08B | 2.27B | 1.57B | 1.62B | 1.73B | 1.83B | 837.46M | 930.84M |
| Common Stock | 19K | 19K | 18K | 18K | 18K | 18K | 16K | 16K | 16K | 16K | 11K | 11K |
| Retained Earnings | -3.32B | -2.87B | -2.5B | -2.2B | -1.95B | -1.74B | -1.54B | -1.39B | -1.25B | -1.14B | -976.17M | -867.74M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -622K | 3.24M | 3.12M | 1.3M | 1.71M | 1.32M | 3.81M | -1.86M | -1.2M | 544K | -871K | -1.25M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |